EGFR and non-small cell lung carcinoma: In addition, gefitinib-resistant, EGFR-mutated NSCLC cells showed a higher content of LDs compared to the parental gefitinib-sensitive PC9 and HCC827 cells, suggesting a role of LD accumulation in EGFR-TKI resistance.